IBDEI3B3 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,639,0)
 ;;=ED OBS (ADMIT&D/C SAME DAY)^2^71
 ;;^UTILITY(U,$J,358.4,640,0)
 ;;=ED COMMON DIAGNOSES^1^72
 ;;^UTILITY(U,$J,358.4,641,0)
 ;;=ADMINISTRATIVE TOPICS^2^72
 ;;^UTILITY(U,$J,358.4,642,0)
 ;;=CARDIOVASCULAR^3^72
 ;;^UTILITY(U,$J,358.4,643,0)
 ;;=EAR/NOSE/THROAT^6^72
 ;;^UTILITY(U,$J,358.4,644,0)
 ;;=ENDO/RENAL/ELECTROLYTES^5^72
 ;;^UTILITY(U,$J,358.4,645,0)
 ;;=EYE^7^72
 ;;^UTILITY(U,$J,358.4,646,0)
 ;;=GI/ABDOMEN^8^72
 ;;^UTILITY(U,$J,358.4,647,0)
 ;;=PSYCHIATRY^17^72
 ;;^UTILITY(U,$J,358.4,648,0)
 ;;=PAIN/LACERATION/WOUNDS^16^72
 ;;^UTILITY(U,$J,358.4,649,0)
 ;;=PULMONARY^18^72
 ;;^UTILITY(U,$J,358.4,650,0)
 ;;=GU/RECTAL^9^72
 ;;^UTILITY(U,$J,358.4,651,0)
 ;;=HEME/ONC/VASCULAR^10^72
 ;;^UTILITY(U,$J,358.4,652,0)
 ;;=INFECTIOUS DISEASE^11^72
 ;;^UTILITY(U,$J,358.4,653,0)
 ;;=MUSCULOSKELETAL/MISC^14^72
 ;;^UTILITY(U,$J,358.4,654,0)
 ;;=NEUROLOGY^15^72
 ;;^UTILITY(U,$J,358.4,655,0)
 ;;=SKIN^19^72
 ;;^UTILITY(U,$J,358.4,656,0)
 ;;=MUSCULOSKELETAL-LE^12^72
 ;;^UTILITY(U,$J,358.4,657,0)
 ;;=MUSCULOSKELETAL-UE^13^72
 ;;^UTILITY(U,$J,358.4,658,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^20^72
 ;;^UTILITY(U,$J,358.4,659,0)
 ;;=E-CIG/VAPE LUNG INJURY (EVAL)^4^72
 ;;^UTILITY(U,$J,358.4,660,0)
 ;;=MISC-FALLS^21^72
 ;;^UTILITY(U,$J,358.4,661,0)
 ;;=MISC-VEHICLE ACCIDENTS^22^72
 ;;^UTILITY(U,$J,358.4,662,0)
 ;;=MISC-BITES,PUNCTURE WOUNDS,ASSAULTS^23^72
 ;;^UTILITY(U,$J,358.4,663,0)
 ;;=TEST - CATARACT / COLOR^4^73
 ;;^UTILITY(U,$J,358.4,664,0)
 ;;=IMAGING / PHOTOS^2^73
 ;;^UTILITY(U,$J,358.4,665,0)
 ;;=TEST - GLAUCOMA^3^73
 ;;^UTILITY(U,$J,358.4,666,0)
 ;;=TEST - OTHER^5^73
 ;;^UTILITY(U,$J,358.4,667,0)
 ;;=REFRACT / GLASSES / CL^1^73
 ;;^UTILITY(U,$J,358.4,668,0)
 ;;=EEF Version 2020 February^6^73
 ;;^UTILITY(U,$J,358.4,669,0)
 ;;=LOW VISION / BLINDNESS^21^74
 ;;^UTILITY(U,$J,358.4,670,0)
 ;;=RETINA - VASCULAR^12^74
 ;;^UTILITY(U,$J,358.4,671,0)
 ;;=EYELIDS / LASHES^2^74
 ;;^UTILITY(U,$J,358.4,672,0)
 ;;=NEURO / STRABISMUS^18^74
 ;;^UTILITY(U,$J,358.4,673,0)
 ;;=ORBIT - PLASTICS^20^74
 ;;^UTILITY(U,$J,358.4,674,0)
 ;;=VITREOUS^17^74
 ;;^UTILITY(U,$J,358.4,675,0)
 ;;=ORBIT - TRAUMA^19^74
 ;;^UTILITY(U,$J,358.4,676,0)
 ;;=LACRIMAL / NLD / NEOPLASMS^3^74
 ;;^UTILITY(U,$J,358.4,677,0)
 ;;=MOST FREQUENT^1^74
 ;;^UTILITY(U,$J,358.4,678,0)
 ;;=CONJUNCTIVA / SCLERA^4^74
 ;;^UTILITY(U,$J,358.4,679,0)
 ;;=CORNEA / ULCER^5^74
 ;;^UTILITY(U,$J,358.4,680,0)
 ;;=LENS / CATARACT / POSTOP^6^74
 ;;^UTILITY(U,$J,358.4,681,0)
 ;;=IRIS / UVEITIS^7^74
 ;;^UTILITY(U,$J,358.4,682,0)
 ;;=GLAUCOMA - OPEN ANGLE^8^74
 ;;^UTILITY(U,$J,358.4,683,0)
 ;;=GLAUCOMA - CLOSED ANGLE^9^74
 ;;^UTILITY(U,$J,358.4,684,0)
 ;;=GLAUCOMA - SECONDARY^10^74
 ;;^UTILITY(U,$J,358.4,685,0)
 ;;=RETINA - CHOROID / TUMORS / INFLAM^14^74
 ;;^UTILITY(U,$J,358.4,686,0)
 ;;=RETINA - TEAR / PERIPH / DEGENERATION^15^74
 ;;^UTILITY(U,$J,358.4,687,0)
 ;;=RETINA - MACULA^11^74
 ;;^UTILITY(U,$J,358.4,688,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^23^74
 ;;^UTILITY(U,$J,358.4,689,0)
 ;;=PMH / OTHER^22^74
 ;;^UTILITY(U,$J,358.4,690,0)
 ;;=RETINA - VEGF INJECT DX CODES^16^74
 ;;^UTILITY(U,$J,358.4,691,0)
 ;;=RETINA - DIABETIC RETINOPATHY^13^74
 ;;^UTILITY(U,$J,358.4,692,0)
 ;;=NEW PATIENT^3^75
 ;;^UTILITY(U,$J,358.4,693,0)
 ;;=ESTABLISHED PATIENT^2^75
 ;;^UTILITY(U,$J,358.4,694,0)
 ;;=CONSULTS - OUTPT^4^75
 ;;^UTILITY(U,$J,358.4,695,0)
 ;;=EYE CODES^1^75
 ;;^UTILITY(U,$J,358.4,696,0)
 ;;=CONSULTS - INPT^5^75
